CSL Ltd
OTC:CMXHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
CSL Ltd (CMXHF) under the Base Case is USD per share.
Compared with the current market price of 136.775 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What CSL Does
CSL Ltd is a global biopharmaceutical company that makes medicines from human plasma and other biological materials. Its main products are treatments for immune disorders, bleeding disorders, and other serious conditions, plus vaccines for influenza and related infectious diseases. The company also sells iron and kidney-care therapies through its specialty medicines business.
- Headquarters
- Australia AU
- Employees
- 32 065
- IPO date
- Jun 8, 1994
CSL has no economic moat
Established rivals can supply competing plasma medicines, while generic alternatives limit protection for parts of CSL’s iron treatment business. CSL’s manufacturing expertise and product approvals create hurdles, but do not by themselves keep capable competitors from pursuing its customers and profits.
Read the full moat analysis
Earnings Waterfall
CSL Ltd
What is the Intrinsic Value of one CMXHF stock?
The intrinsic value for CSL Ltd (CMXHF) under the Base Case is USD.
Is CMXHF stock undervalued or overvalued?
Compared with the current market price of 136.775 USD, the stock appears .
